ATG-thymoglobulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATG-thymoglobulin, covering 2026-04-27 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor [Phase 3]